DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Mayer IA, Prat A, Egle D. et al.
A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB).
Clin Cancer Res 2019;
25: 2975-2987
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.